These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36389018)

  • 21. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
    Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
    BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
    Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
    Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progranulin and Activin A Concentrations are Elevated in Serum from Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
    Xie T; Han L; Chen Y; Wu H
    Lung; 2021 Oct; 199(5):467-473. PubMed ID: 34462814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.
    Cao MS; Sheng J; Wang TZ; Qiu XH; Wang DM; Wang Y; Xiao YL; Cai HR
    Chin Med J (Engl); 2019 Sep; 132(18):2177-2184. PubMed ID: 31490258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
    Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
    Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
    Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
    Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between serum bilirubin levels and the severity as well as the prognosis of idiopathic pulmonary fibrosis.
    Shi S; Liu Y; Qiu X; Cao M; Xiao Y; Yan X
    Chron Respir Dis; 2020; 17():1479973120957676. PubMed ID: 32909821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Cao M; Swigris JJ; Wang X; Cao M; Qiu Y; Huang M; Xiao Y; Cai H
    Mediators Inflamm; 2016; 2016():6940480. PubMed ID: 27642238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
    Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
    Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis.
    Kondoh Y; Taniguchi H; Katsuta T; Kataoka K; Kimura T; Nishiyama O; Sakamoto K; Johkoh T; Nishimura M; Ono K; Kitaichi M
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(2):103-10. PubMed ID: 21319592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker.
    Tachibana K; Inoue Y; Nishiyama A; Sugimoto C; Matsumuro A; Hirose M; Kitaichi M; Akira M; Arai T; Hayashi S; Inoue Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):113-22. PubMed ID: 22117502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study.
    Arai T; Akira M; Sugimoto C; Tachibana K; Inoue Y; Shintani S; Okuma T; Kasai T; Hayashi S; Inoue Y
    J Thorac Dis; 2020 Aug; 12(8):4132-4147. PubMed ID: 32944325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study.
    Huang TH; Kuo CW; Chen CW; Tseng YL; Wu CL; Lin SH
    BMC Pulm Med; 2021 May; 21(1):165. PubMed ID: 33992083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute exacerbation in antineutrophil cytoplasmic antibody-associated interstitial lung disease: Clinical features and risk factors.
    Otsuka J; Yoshizawa S; Ikematsu Y; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2022 Nov; 203():106992. PubMed ID: 36252462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
    Akiyama N; Hozumi H; Isayama T; Okada J; Sugiura K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respirology; 2020 Jul; 25(7):743-749. PubMed ID: 31597225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis.
    Sakamoto S; Shimizu H; Isshiki T; Nakamura Y; Usui Y; Kurosaki A; Isobe K; Takai Y; Homma S
    Sci Rep; 2022 Jan; 12(1):1134. PubMed ID: 35064161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.